Publications by authors named "Solveig N Daecke"

Claim this Profile
D
Dexamethasone induced Dectin-1 activation enhances NLRP3 inflammasome activation.
Ruth-Miriam Koerber, Sebastian Oberbeck, Philipp Kotthoff, Solveig N Daecke, Peter Brossart

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spoilt for choice: different immunosuppressive potential of anaplastic lymphoma kinase inhibitors for non small cell lung cancer.
Annkristin Heine, Stefanie Andrea Erika Held, Solveig Nora Daecke, Chrystel Flores, Peter Brossart

Front Immunol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells.
Christiane Braun, Sebastian Schlaweck, Solveig Nora Daecke, Peter Brossart, Annkristin Heine

Cancer Immunol Immunother· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pacritinib protects dendritic cells more efficiently than ruxolitinib.
Annkristin Heine, Anna Maria Wolf, Sebastian Schlaweck, Solveig Nora Daecke, Peter Brossart

Exp Hematol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and functional characterization of MDSC-like cells.
Annkristin Heine, Stefanie Andrea Erika Held, Jonas Schulte-Schrepping, Julia Friederike Andrea Wolff, Kathrin Klee, Solveig Nora Daecke

Oncoimmunology· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function.
Annkristin Heine, Stefanie Andrea Erika Held, Solveig Nora Daecke, Kati Riethausen, Philipp Kotthoff

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma.
Ruth-Miriam Koerber, Stefanie Andrea Erika Held, Annkristin Heine, Philipp Kotthoff, Solveig Nora Daecke

Exp Hematol Oncol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo.
Annkristin Heine, Stefanie Andrea Erika Held, Solveig Nora Daecke, Stephanie Wallner, Sowmya Parampalli Yajnanarayana

Blood· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis